Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AVTR | RGEN |
|---|---|---|
| Price | $15.81 | $189.50 |
| Change today | ▲ 3.06% | ▲ 4.29% |
| Market cap | $10.69B | $10.69B |
| Return, 3 months | +55.0% | +35.5% |
| Return, year to date | +38.0% | +15.6% |
| Return, 1 year | +12.2% | +26.2% |
| P/E (TTM) | -18.6 | 259.6 |
| P/B | 1.9 | 5.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 64 | 59 |
| 30-day volatility | 29.7% | 44.1% |
| Max drawdown, 1 year | -52.5% | -40.3% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
